Indus MedTech Solutions is a medical-device-focused medical and regulatory writing company. We help manufacturers develop and maintain EU MDR clinical evaluation and postmarket documents as one connected evidence system rather than as isolated reports produced by different teams.
EU MDR documentation works as a connected evidence system. IMTS supports manufacturers across clinical evaluation, postmarket surveillance, PMCF, periodic reporting, and public facing safety summaries so that conclusions remain aligned across the technical documentation.
Disconnected documents create avoidable inconsistencies in claims, evidence, risk conclusions, and postmarket commitments. Our writers preserve a coherent clinical story across the documents reviewed by notified bodies.
Direct answers
Questions medical device teams ask.
What EU MDR documents does IMTS write?
IMTS writes Clinical Evaluation Plans and Reports (CEP/CER), Post-Market Surveillance Plans and Reports, PMCF Plans and Evaluation Reports, Periodic Safety Update Reports (PSUR), Summaries of Safety and Clinical Performance (SSCP), and supporting systematic literature reviews.
How does IMTS keep EU MDR documents consistent?
We align the device description, intended purpose, claims, clinical evidence, risks, benefit-risk conclusions, postmarket findings, and future evidence commitments across the CER, PMS, PMCF, PSUR, SSCP, labeling, and related source documents.
When should a manufacturer engage IMTS for EU MDR writing?
Manufacturers engage IMTS for new submissions, recurring updates, portfolio programs, remediation after notified body findings, evidence-gap assessment, and temporary writing capacity when internal clinical or regulatory teams need specialized support.
Why choose IMTS for EU MDR medical writing?
IMTS combines medical-device specialization, more than 300 CERs authored, advanced-degree writers, and boutique accountability. Our work is designed to create traceable conclusions that can be reviewed efficiently by internal teams and notified bodies.
Scope of support
What we can deliver.
01Clinical Evaluation Plans and Reports
02Postmarket Surveillance Plans and Reports
03PMCF Plans and Evaluation Reports
04Periodic Safety Update Reports
05Summaries of Safety and Clinical Performance
How we work
A focused path from source evidence to final document.
01
Map the document ecosystem
Identify the required documents, source records, dependencies, review cycle, and stakeholder responsibilities.
02
Align the evidence
Use consistent device descriptions, claims, risk conclusions, clinical data, and postmarket findings across deliverables.
03
Prepare for review
Strengthen traceability, resolve gaps, and support responses when notified body questions require focused revision.
Related IMTS perspective
How CER, PMS, PMCF, PSUR, and SSCP Must Remain Aligned Under EU MDR
A practical IMTS framework for controlling shared evidence, risks, conclusions, and postmarket commitments across the EU MDR document lifecycle.